TY - JOUR
T1 - How Valid Are the Rates of Down Syndrome Internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and Research
AU - Leoncini, Emanuele
AU - Botto, Lorenzo D.
AU - Cocchi, Guido
AU - Anneren, Goran
AU - Bower, Carol
AU - Halliday, Jane
AU - Amar, Emmanuelle
AU - Bakker, Marian K.
AU - Bianca, Sebastiano
AU - Canessa Tapia, Maria Aurora
AU - Castilla, Eduardo E.
AU - Csaky-Szunyogh, Melinda
AU - Dastgiri, Saeed
AU - Feldkamp, Marcia L.
AU - Gatt, Miriam
AU - Hirahara, Fumiki
AU - Landau, Danielle
AU - Lowry, R. Brian
AU - Marengo, Lisa
AU - McDonnell, Robert
AU - Mathew, Triphti M.
AU - Morgan, Margery
AU - Mutchinick, Osvaldo M.
AU - Pierini, Anna
AU - Poetzsch, Simone
AU - Ritvanen, Annukka
AU - Scarano, Gioacchino
AU - Siffel, Csaba
AU - Sipek, Antonin
AU - Szabova, Elena
AU - Tagliabue, Giovanna
AU - Vollset, Stein Emil
AU - Wertelecki, Wladimir
AU - Zhuchenko, Ludmila
AU - Mastroiacovo, Pierpaolo
PY - 2010/7
Y1 - 2010/7
N2 - Rates of Down syndrome (DS) show considerable international variation, but a systematic assessment of this variation is lacking. The goal of this study was to develop and test a method to assess the validity of DS rates in surveillance programs, as an indicator of quality of ascertainment. The proposed method compares the observed number of cases with DS (livebirths plus elective pregnancy terminations, adjusted for spontaneous fetal losses that would have occurred if the pregnancy had been allowed to continue) in each single year of maternal age, with the expected number of cases based on the best-published data on rates by year of maternal age. To test this method we used data from birth years 2000 to 2005 from 32 surveillance programs of the International Clearinghouse for Birth Defects Surveillance and Research. We computed the adjusted observed versus expected ratio (aOE) of DS birth prevalence among women 25-44 years old. The aOE ratio was close to unity in 13 programs (the 95% confidence interval included 1), above 1 in 2 programs and below 1 in 18 programs (P <0.05). These findings suggest that DS rates internationally can be evaluated simply and systematically, and underscores how adjusting for spontaneous fetal loss is crucial and feasible. The aOE ratio can help better interpret and compare the reported rates, measure the degree of under- or over-registration, and promote quality improvement in surveillance programs that will ultimately provide better data for research, service planning, and public health programs. (C) 2010 Wiley-Liss, Inc.
AB - Rates of Down syndrome (DS) show considerable international variation, but a systematic assessment of this variation is lacking. The goal of this study was to develop and test a method to assess the validity of DS rates in surveillance programs, as an indicator of quality of ascertainment. The proposed method compares the observed number of cases with DS (livebirths plus elective pregnancy terminations, adjusted for spontaneous fetal losses that would have occurred if the pregnancy had been allowed to continue) in each single year of maternal age, with the expected number of cases based on the best-published data on rates by year of maternal age. To test this method we used data from birth years 2000 to 2005 from 32 surveillance programs of the International Clearinghouse for Birth Defects Surveillance and Research. We computed the adjusted observed versus expected ratio (aOE) of DS birth prevalence among women 25-44 years old. The aOE ratio was close to unity in 13 programs (the 95% confidence interval included 1), above 1 in 2 programs and below 1 in 18 programs (P <0.05). These findings suggest that DS rates internationally can be evaluated simply and systematically, and underscores how adjusting for spontaneous fetal loss is crucial and feasible. The aOE ratio can help better interpret and compare the reported rates, measure the degree of under- or over-registration, and promote quality improvement in surveillance programs that will ultimately provide better data for research, service planning, and public health programs. (C) 2010 Wiley-Liss, Inc.
KW - Down syndrome
KW - epidemiology
KW - prevalence
KW - validity
KW - registries
KW - MATERNAL AGE INTERVALS
KW - EUROPEAN ORIGIN
KW - SOUTH-AMERICA
KW - UNITED-STATES
KW - ASCERTAINMENT
KW - PREVALENCE
KW - REGISTRY
KW - EPIDEMIOLOGY
KW - PREVENTION
KW - LIVEBIRTH
U2 - 10.1002/ajmg.a.33493
DO - 10.1002/ajmg.a.33493
M3 - Article
VL - 152A
SP - 1670-+
JO - American Journal of Medical Genetics. Part A
JF - American Journal of Medical Genetics. Part A
SN - 1552-4825
IS - 7
ER -